Navarro L, Min R J, Boné C
Vein Treatment Center and Beth Israel Medical Center, New York, New York 10021, USA.
Dermatol Surg. 2001 Feb;27(2):117-22. doi: 10.1046/j.1524-4725.2001.00134.x.
Long-term success in the treatment of truncal and significant branch leg varicosities, when the saphenofemoral junction (SFJ) and the greater saphenous vein (GSV) are involved, depends on the elimination of the highest point of reflux and the incompetent venous segment, and is best achieved by surgical ligation and stripping. Minimally invasive alternatives in the treatment of varicose veins with SFJ and GSV incompetence have been tried over the years to increase patient comfort, reduce cost and risk, and allow implementation by a wide variety of practitioners resulting in varying degrees of success depending on the fulfillment of the above two premises and the effectiveness of the method used.
To demonstrate a novel way to use laser energy through an endoluminal laser fiber for the minimally invasive treatment of truncal varicosities that eliminates the highest point of reflux and the incompetent segment.
Patients were treated with 810 nm diode laser energy administered endovenously through a bare-tipped laser fiber (400-750 microm). Vein access for endoluminal placement of the fiber through a catheter was achieved by means of percutaneous or stab wound incision under ultrasound guidance and local anesthesia. Exact placement of the fiber was determined by direct observation of the aiming beam through the skin and by ultrasound confirmation.
Preliminary short-term postprocedure results (up to 1 year, 2 months after treatment) in the endovenous laser treatment of 40 greater saphenous veins in 33 patients indicate a 100% rate of closure with no significant complications. In addition, a 2-year experience of 80 cases of isolated branch varicosities (Giacomini, anterolateral branch, etc.) also shows a 100% rate of closure.
Early results of our endoluminal laser methodology indicate a very effective and safe way to eliminate SFJ incompetence and close the GSV. With proper patient selection, the ease of methodology and the reduced risk and cost associated with endovenous laser treatment may make it a successful minimally invasive alternative for a wide group of patients that previously would have required ligation and stripping.
当隐股静脉交界处(SFJ)和大隐静脉(GSV)受累时,治疗躯干和严重分支腿部静脉曲张的长期成功取决于消除反流的最高点和功能不全的静脉段,而通过手术结扎和剥脱术能最好地实现这一目标。多年来,人们尝试了多种治疗伴有SFJ和GSV功能不全的静脉曲张的微创方法,以提高患者舒适度、降低成本和风险,并使各种从业者都能实施,其成功程度取决于上述两个前提条件的满足情况以及所用方法的有效性。
展示一种通过腔内激光光纤使用激光能量的新方法,用于微创治疗躯干静脉曲张,以消除反流的最高点和功能不全的静脉段。
患者通过裸端激光光纤(400 - 750微米)经静脉给予810纳米二极管激光能量进行治疗。在超声引导和局部麻醉下,通过经皮穿刺或小切口将光纤经导管腔内放置到静脉中。通过直接观察透过皮肤的瞄准光束并经超声确认来确定光纤的准确位置。
对33例患者的40条大隐静脉进行静脉内激光治疗后的初步短期术后结果(治疗后长达1年零2个月)显示,闭合率为100%,且无明显并发症。此外,80例孤立分支静脉曲张( Giacomini静脉、前外侧分支等)的2年经验也显示闭合率为100%。
我们的腔内激光方法的早期结果表明,这是一种消除SFJ功能不全和闭合GSV的非常有效且安全的方法。通过适当选择患者,该方法操作简便,且与静脉内激光治疗相关的风险和成本降低,这可能使其成为一大类以前需要结扎和剥脱术的患者的成功微创替代方法。